Debora Marks
Corporate Officer/Principal chez Institute For Protein Innovation, Inc.
Provenance du réseau au premier degré de Debora Marks
Entité | Type d'entité | Industrie | |
---|---|---|---|
Institute For Protein Innovation, Inc.
Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022.
11
| Non-Profit Organization | Miscellaneous Commercial Services | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Debora Marks via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Director/Board Member | |
SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Founder Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Founder Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Parexel International Corp. Ltd.
Parexel International Corp. Ltd. Financial ConglomeratesFinance Parexel International Corp. Ltd. functions as an investment holding British company. The private company is based in Basingstoke, UK. | Financial Conglomerates | Director/Board Member | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member | |
FIBROGEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Sales & Marketing | |
The Aaron Diamond AIDS Research Center
The Aaron Diamond AIDS Research Center Miscellaneous Commercial ServicesCommercial Services The Aaron Diamond AIDS Research Center for the City of New York, Inc. provides research and clinical testing solutions for HIV and AIDS. The firm focuses on basic science of AIDS and its related research. The company was founded by Irene Diamonds on April 16, 1991 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Viridian Global Logistics, Inc. | Corporate Officer/Principal | ||
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Matter Neuroscience is an American company that develops mobile applications for neurological reward systems. The private company was founded by Benjamin Goldhirsh and Axel Bouchon, with Axel Bouchon serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity | |
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
Soufflé Therapeutics, Inc.
Soufflé Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Soufflé Therapeutics, Inc. engages in pharmaceutical research and development services. The company is based in Newton, MA. The CEO of the company is Amir H. Nashat. | Pharmaceuticals: Other | Chief Executive Officer | |
Alioth, Inc.
Alioth, Inc. Packaged SoftwareTechnology Services Alioth, Inc. operates as a hiring success platform. The private company is based in Spicewood, TX. The company was founded in 2018 by Amir H. Nashat, Kenneth A. DiPietro, Janet Stafford, James Russell Rueff. Janet Stafford has been the CEO since 2018. | Packaged Software | Founder | |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Biotechnology | Chairman | |
Taris Holdings LLC | Director/Board Member | ||
Brain Games Corp. | Director/Board Member | ||
THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
The City College of New York | College/University | Undergraduate Degree | |
NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer | |
University of Berkley | College/University | Undergraduate Degree | |
GV Management Co. LLC
GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor | |
University of Kansas | College/University | Undergraduate Degree | |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Chief Executive Officer | |
501 ACQU | Financial Conglomerates | Director/Board Member | |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Operating Officer | |
Harvard Business School | College/University | Masters Business Admin | |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
The Rockefeller University | College/University | Graduate Degree | |
Dupont De Nemours & Co., Inc.
Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Part of Corteva, Inc., Dupont De Nemours & Co., Inc. is a company that manufactures hybrid corn and soybean seeds. The company is based in Wilmington, DE. | Agricultural Commodities/Milling | Sales & Marketing | |
CUE BIOPHARMA, INC. | Biotechnology | Founder | |
New York Structural Biology Center, Inc.
New York Structural Biology Center, Inc. BiotechnologyHealth Technology New York Structural Biology Center, Inc. provides resources in structural biology to its members and outside users. Its services include advanced instrumentation and expertise for NMR, X-ray crystallography and electron microscopy. The company was founded in 1999 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Harvard NeuroDiscovery Center, Inc.
Harvard NeuroDiscovery Center, Inc. BiotechnologyHealth Technology Harvard NeuroDiscovery Center, Inc. operates as a pioneering biomedical research group focused on ending suffering from neurodegenerative and psychiatric diseases. The company was founded in 2001 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
SIGILON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 49 |
Royaume-Uni | 2 |
Chine | 2 |
Sectorielle
Health Technology | 24 |
Consumer Services | 11 |
Finance | 8 |
Commercial Services | 4 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 84 |
Independent Dir/Board Member | 21 |
Corporate Officer/Principal | 13 |
Chief Executive Officer | 12 |
Founder | 11 |
Relations les plus connectées
Insiders | |
---|---|
Amir Nashat | 51 |
Timothy Springer | 19 |
May Kin Ho | 16 |
Jeffrey Flier | 12 |
Samantha Singer | 9 |
Issi Rozen | 4 |
Steven Almo | 3 |
Stephen Blacklow | 3 |
Will Somers | 1 |
Kenneth Fasman | 1 |
Mike O'Hara | 1 |
- Bourse
- Insiders
- Debora Marks
- Connexions Sociétés